Life Sciences & Healthcare

The Indian pharmaceutical industry is the world's second-largest by volume and is likely to lead the manufacturing sector of India. The huge potential of the Indian pharmaceuticals market is impossible for foreign companies to ignore, given that it will be one of the top 10 sales markets by 2020. The total market is expected to rise to a value of approximately US$50 billion by 2020. Indian companies are among the world leaders in the production of generics and vaccines - now producing more than 20% of the world’s generics. Around $70 billion worth of drugs are expected to go off patent in the US over the next three years and India is capable of manufacturing a substantial share of the product to support the resulting generics opportunities.

Clientele :

  • Medical Technology & Devices.
  • Healthcare IT.
  • Pharma.
Functional Areas: